Archives
COVID-19: Takeda's Biolife Locations Collecting Plasma for Therapy
The plasma from healthy individuals who recovered for COVID-19 is being collected at BioLife Plasma Services, a part of Takeda Pharmaceutical Company Ltd. The valuable plasma will be used to develop a potential therapy for COVID-19.
Latest Research Articles
-
COVID-19: 100% Survival Rate Therapy of Israeli-based Pluristem Tested on US patient
-
Invasive Plant Bacterium Could Jeopardize the Olive Oil Industry
-
Top Picks Universal Travel Adapter
-
Sweden is Trying to Beat the COVID-19 Pandemic Without Complete Lockdown
-
Baby's Gender Depends on Father's Genes, Study Says
-
What Does Single Touch Payroll Mean For Employees
-
Preliminary Discovery: First 'Significant' SARS-CoV-2 Mutation
-
African-Americans Most Likely to Get COVID-19: Here Are Reasons Why
-
Quarantine Binge Drinking May End Badly
-
Ten Previously Thought Extinct Apple Varieties Found Again in Pacific Northwest
-
The Evolution of Rain’s Distinct Scent and Its Role in Bacterial Propagation
-
Ideal Gaming Gift Gadgets This Season For Your Loved Ones
MOST POPULAR
-
Hurricane Melissa Jamaica Updates: Tourism Shutdowns and Economic Fallout Loom as Category 4 Storm Nears Landfall
-
Supermoon 2025: November 5 Delivers 14% Bigger, 30% Brighter Lunar Show
-
Hurricane Melissa Targets Southeast Bahamas and Bermuda After Historic Category 5 Jamaica Landfall
-
Florida Teen Survives Alligator Attack by 'Punching It in the Head'
-
Millionaire CEO Trampled to Death By His Own Elephant on South African Game Reserve
